[Federal Register Volume 62, Number 181 (Thursday, September 18, 1997)]
[Rules and Regulations]
[Pages 48939-48940]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-24736]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 510
New Animal Drugs; Change of Sponsor Address
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor address for K. C.
Pharmacal, Inc.
EFFECTIVE DATE: September 18, 1997.
FOR FURTHER INFORMATION CONTACT: Judith O'Haro, Center for Veterinary
Medicine (HFV-6), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-827-3664.
SUPPLEMENTARY INFORMATION: K. C. Pharmacal, Inc., 1310 Atlantic, P.O.
Box 7496, North Kansas City, MO 64116, has informed FDA of a change of
sponsor address to K. C. Pharmacal, Inc., 8345 Melrose Dr., Lenexa, KS
66214. Accordingly, the agency is amending the regulations in 21 CFR
510.600(c)(1) and (c)(2) to reflect the change of sponsor address.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is
amended as follows:
PART 510--NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 510 continues to read as
follows:
Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352,
353, 360b, 371, 379e).
2. Section 510.600 is amended in the table in paragraph (c)(1) by
revising the sponsor address for ``K. C. Pharmacal, Inc.'' and in the
table in paragraph (c)(2) in the entry for ``038782'' by revising the
sponsor address to read as follows:
Sec. 510.600 Names, addresses, and drug labeler codes of sponsors of
approved applications.
* * * * *
(c) * * *
(1) * * *
------------------------------------------------------------------------
Firm name and address Drug labeler code
------------------------------------------------------------------------
* * * *
* * *
K. C. Pharmacal, Inc., 8345 Melrose Dr., 038782
Lenexa, KS 66214.
* * * *
* * *
------------------------------------------------------------------------
(2) * * *
[[Page 48940]]
------------------------------------------------------------------------
Drug labeler code Firm name and address
------------------------------------------------------------------------
* * * *
* * *
038782................................... K. C. Pharmacal, Inc., 8345
Melrose Dr., Lenexa, KS
66214
* * * *
* * *
------------------------------------------------------------------------
Dated: September 4, 1997.
George A. Mitchell,
Acting Director, Center for Veterinary Medicine.
[FR Doc. 97-24736 Filed 9-17-97; 8:45 am]
BILLING CODE 4160-01-F
